Reaction Biology Europe GmbH

ProQinase is a leading contract research organization (CRO) for drug discovery in oncology.

Our platform of products and services includes
- production and sale of recombinant kinase enzymes
- biochemical assays for screening of kinase inhibitors
- cellular assays for screening of cancer drugs in various 2D and 3D systems
- animal models for investigation of the impact of cancer drugs on growth of tumors in mice.

Furthermore, we offer an integrated drug discovery platform:
Our longstanding experience in the development of kinase inhibitors together with the expertise of two chemistry partners, Mercachem and Novalix, enables us to complete drug discovery projects covering all steps in the drug discovery and pre-clinical phase starting with compound design and ending with proof on concept studies in mice.